Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control

Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control

ABSTRACT Objective To evaluate the effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus (T2DM) and inadequate glycemic control. Materials and methods A randomized, double-blind, placebo-controlled clinical trial was carried out on 12 patients with T2DM and inad...

Full description

Bibliographic Details
Main Authors:	Miriam Méndez-del Villar, Esperanza Martínez-Abundis, Rafael O. Preciado-Márquez, Manuel González-Ortiz
Format:	Article
Language:	English
Published:	Brazilian Society of Endocrinology and Metabolism 2017-02-01
Series:	Archives of Endocrinology and Metabolism
Subjects:	Diacerein metformin glycemic control type 2 diabetes mellitus
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000200188&lng=en&tlng=en

Similar Items

Diacerein, its beneficial impact on chondrocytes and notable new clinical applications
by: Daljit Kaur, et al.
Published: (2019-04-01)

Efficacy and safety of diacerein in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2017-09-01)

Diacerein: A potential therapeutic drug for the management of experimental periodontitis in rats
by: Basma Mostafa Zaki, et al.
Published: (2015-09-01)

Metformin improves glycemic variability in adults with type 1 diabetes mellitus: an open-label randomized control trial
by: Xiuzhen Zhang, et al.
Published: (2021-09-01)

Diacerein: Advantages and disadvantages
by: Andrei Evgenyevich Karateev
Published: (2014-12-01)

Diacerein: Advantages and disadvantages
by: Andrei Evgenyevich Karateev
Published: (2014-12-01)

Diacerein in the treatment of osteoarthritis in patients with comorbidity
by: E. P. Sharapova, et al.
Published: (2018-12-01)

PREPARATION AND CHARACTERIZATION OF CO-CRYSTALS OF DIACEREIN
by: Raju Rameshrao Thenge, et al.
Published: (2017-01-01)

Determination of Picogram Levels of Diacerein in a Pharmaceutical Formulation by Flow-Injection Chemiluminescence
by: Gao Suya, et al.
Published: (2017-01-01)

Atorvastatin and diacerein reduce insulin resistance and increase disease tolerance in rats with sepsis
by: K. L. C. da Silva, et al.
Published: (2018-05-01)

Diacerein Ameliorates Liver Ischemia Reperfusion Insult in Rats
by: Soad L. Kabil
Published: (2018-08-01)

Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes
by: Derosa G, et al.
Published: (2017-05-01)

Diacerein for osteoarthritis: An open-label comparative trial
by: L. V. Luchikhina, et al.
Published: (2016-03-01)

Diacerein: Recent insight into pharmacological activities and molecular pathways
by: Maged Almezgagi, et al.
Published: (2020-11-01)

DIACEREIN AS THE DRUG OF CHOICE IN THE THERAPY OF KNEE OSTEOARTHRITIS WITH SECONDARY RECURRENT SYNOVITIS
by: M. I. Udovika
Published: (2016-02-01)

Diacerein the treatment of osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2016-12-01)

Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study
by: Guoli Du, et al.
Published: (2020-10-01)

Prediction of diacerein inhibition activity against interleukin-1 receptors through docking method and tracing of pharmacokinetic profiles and their toxicity
by: Frengki Frengki, et al.
Published: (2020-11-01)

Use of diacerein for the treatment of large joint osteoarthritis (A review of literature and the author’s own experience)
by: Rimma Mikhailovna Balabanova
Published: (2015-09-01)

EVALUATION OF THE EFFICACY AND SAFETY OF DIACEREIN IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP JOINTS
by: E. P. Sharapova, et al.
Published: (2017-12-01)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
by: Paresh Ved, et al.
Published: (2012-01-01)

Pharmacological treatment with diacerein combined with mechanical stimulation affects the expression of growth factors in human chondrocytes
by: Bibiane Steinecker-Frohnwieser, et al.
Published: (2017-09-01)

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex
by: Michael Ablinger, et al.
Published: (2018-11-01)

Anti-Contractile and Anti-Inflammatory Effects of Diacerein on Isolated Mouse Airways Smooth Muscle and Mouse Asthma Model
by: Shunbo Shi, et al.
Published: (2020-09-01)

Effects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus
by: Ali I Al-Gareeb, et al.
Published: (2016-01-01)

ESTIMATION OF DIACEREIN TOLERABILITY IN REAL CLINICAL PRACTICE: RESULTS OF THE RACADA (RETROSPECTIVE ASSESSMENT OF CLINICAL ASPECTS OF USING DIAFLEX IN OSTEOARTHRITIS)
by: A. E. Karateev, et al.
Published: (2015-04-01)

Corneal pharmacokinetics of the 2% diacerein eye drops between multiple administration and single administration
by: Ke Yang, et al.
Published: (2018-04-01)

Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation
by: Allam AN, et al.
Published: (2017-07-01)

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus with inadequate glycemic control on metformin: a meta-analysis
by: Zhang Jingfan, et al.

Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol
by: Edith Pascale Mofo Mato, et al.
Published: (2018-07-01)

Inhibition of inflammation using diacerein markedly improved renal function in endotoxemic acute kidney injured mice
by: Guangzhe Yu, et al.
Published: (2018-08-01)

Diacerein protects rats with liver ischemia/reperfusion damage: Down-regulation of TLR4/ NFκ-B signaling pathway
by: Mohamed Abdellah Ibrahim, et al.
Published: (2021-02-01)

Diacerein-Loaded Hyaluosomes as a Dual-Function Platform for Osteoarthritis Management via Intra-Articular Injection: In Vitro Characterization and In Vivo Assessment in a Rat Model
by: Nouran O. Eladawy, et al.
Published: (2021-05-01)

Evaluation of Vitamin B12 status in type 2 Diabetes Mellitus Patients on Metformin therapy
by: Ananda Vayaravel Cassinadane, et al.
Published: (2018-03-01)

Pharmacoeconomic analysis of modern oral hypoglycemic agents with inadequate glycemic control on metformin
by: M. F. Kalashnikova, et al.
Published: (2019-08-01)

Metformin versus insulin in the management of gestational diabetes mellitus
by: Ola Amer Mahmood
Published: (2019-01-01)

Towards defining criteria for metformin usage in management of Gestational Diabetes Mellitus.
by: Hamidreza Mahboobi, et al.
Published: (2010-07-01)

Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia
by: Gebrie D, et al.
Published: (2021-07-01)

Efficacy and safety of teneligliptin added to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin: A phase 3, randomized, double‐blind, placebo‐controlled study
by: Linong Ji, et al.
Published: (2021-04-01)

Comparative evaluation of efficacy and safety of combination of metformin-vidagliptin versus metfromin-glimepiride in most frequently used doses in patients of type 2 diabetes mellitus with inadequately controlled metformin monotherapy-A randomised open label study
by: Shallini Gupta, et al.
Published: (2015-01-01)